Kiniksa Pharmaceuticals, Ltd. (KNSA) Profit Margin
Kiniksa Pharmaceuticals, Ltd. (KNSA) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2018-12-31 | N/A |
| 2019-12-31 | N/A |
| 2020-12-31 | N/A |
| 2021-12-31 | -409.72% |
| 2022-12-31 | 83.28% |
| 2023-12-31 | 5.21% |
| 2024-12-31 | -10.21% |
| 2025-12-31 | 8.71% |
How KNSA compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| UHS | Universal Health Services Inc. | 8.57% |
| ZBH | Zimmer Biomet Holdings Inc. | 8.57% |
| MMSI | Merit Medical Systems Inc. | 8.48% |
| NRC | National Research Corporation | 8.44% |
| IQV | IQVIA Holdings Inc. | 8.34% |
These are five companies in the same sector as KNSA with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Kiniksa Pharmaceuticals, Ltd. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("KNSA", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | KNSA | $76.75 | +0.00% | 0.45M |
| 3 | ||||
| 4 | ||||
| 5 |